Patent · US Active

CYP17 inhibitors/antiandrogens

US9890139B2 · kind B2 · utility

0Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 10, 2014
Grant dateFeb 13, 2018
Priority date—
Expiry dateJun 10, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.